Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Routman

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Journal of Neurosurgery|January 22, 2026
Prognostic factors for 90-day survival after stereotactic radiosurgery for brain metastasis patientsAli Gharibi Loron, William D Chow, Andrew D Pumford, et al.
Practical Radiation Oncology|July 17, 2019
A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal CancerAurelie Garant, Thomas J Whitaker, Grant M Spears, et al.
Oral Oncology|July 27, 2020
T cell fraction impacts oncologic outcomes in human papillomavirus associated oropharyngeal squamous cell carcinomaKathryn M Van Abel, David M Routman, Eric J Moore, et al.
Oral Oncology|November 2, 2025
Sensitivity of post-treatment surveillance in detecting recurrence and metastasis in surgically treated HPV-positive oropharyngeal squamous cell carcinoma patientsAgnes Q Zhu, Claire E Cassianni, Travis Haller, et al.
Advances in Radiation Oncology|July 11, 2022
The Number of Radiographically Positive Lymph Nodes Further Stratifies Patient Survival Among Clinical N1 Patients With Human Papillomavirus-Associated Oropharyngeal CancerRoman O Kowalchuk, Kathryn M Van Abel, Adam B Sauer, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 2017
Relapse Rates With Surgery Alone in Human Papillomavirus-Related Intermediate- and High-Risk Group Oropharynx Squamous Cell Cancer: A Multi-Institutional ReviewDavid M Routman, Ryan K Funk, Kanograt Tangsriwong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2020
Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancerGohar S Manzar, Scott C Lester, David M Routman, et al.
Cancers|January 23, 2024
Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck TumorsRobert L Foote, W Scott Harmsen, Adam C Amundson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell CarcinomaDavid M Routman, Sunil Kumar, Bisham S Chera, et al.
Oral Oncology|September 17, 2023
Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated diseaseKathleen R Bartemes, Benjamin R Gochanour, David M Routman, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Journal of Neurosurgery|January 22, 2026
Prognostic factors for 90-day survival after stereotactic radiosurgery for brain metastasis patientsAli Gharibi Loron, William D Chow, Andrew D Pumford, et al.
Practical Radiation Oncology|July 17, 2019
A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal CancerAurelie Garant, Thomas J Whitaker, Grant M Spears, et al.
Oral Oncology|July 27, 2020
T cell fraction impacts oncologic outcomes in human papillomavirus associated oropharyngeal squamous cell carcinomaKathryn M Van Abel, David M Routman, Eric J Moore, et al.
Oral Oncology|November 2, 2025
Sensitivity of post-treatment surveillance in detecting recurrence and metastasis in surgically treated HPV-positive oropharyngeal squamous cell carcinoma patientsAgnes Q Zhu, Claire E Cassianni, Travis Haller, et al.
Advances in Radiation Oncology|July 11, 2022
The Number of Radiographically Positive Lymph Nodes Further Stratifies Patient Survival Among Clinical N1 Patients With Human Papillomavirus-Associated Oropharyngeal CancerRoman O Kowalchuk, Kathryn M Van Abel, Adam B Sauer, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 2017
Relapse Rates With Surgery Alone in Human Papillomavirus-Related Intermediate- and High-Risk Group Oropharynx Squamous Cell Cancer: A Multi-Institutional ReviewDavid M Routman, Ryan K Funk, Kanograt Tangsriwong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2020
Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancerGohar S Manzar, Scott C Lester, David M Routman, et al.
Cancers|January 23, 2024
Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck TumorsRobert L Foote, W Scott Harmsen, Adam C Amundson, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell CarcinomaDavid M Routman, Sunil Kumar, Bisham S Chera, et al.
Oral Oncology|September 17, 2023
Assessing the capacity of methylated DNA markers of cervical squamous cell carcinoma to discriminate oropharyngeal squamous cell carcinoma in human papillomavirus mediated diseaseKathleen R Bartemes, Benjamin R Gochanour, David M Routman, et al.
Pageof 11